These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7965345)

  • 1. Regulation of health care by the insurance industry.
    Weiss L
    J Oral Maxillofac Surg; 1994 Dec; 52(12):1347. PubMed ID: 7965345
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical decision making: from theory to practice. Three battles to watch in the 1990s.
    Eddy DM
    JAMA; 1993 Jul; 270(4):520-6. PubMed ID: 8320794
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical decision making: from theory to practice. What do we do about costs?
    Eddy DM
    JAMA; 1990 Sep; 264(9):1161, 1165, 1169-70. PubMed ID: 2117076
    [No Abstract]   [Full Text] [Related]  

  • 4. [Regress for expensive medicines? When costly therapies are not a problem].
    Nitz G
    MMW Fortschr Med; 2013 Feb; 155(3):12. PubMed ID: 23573755
    [No Abstract]   [Full Text] [Related]  

  • 5. Rethinking "woman's choice" of cesarean delivery.
    Liu CN; Yang MC
    Am J Public Health; 2003 Jul; 93(7):1036-7. PubMed ID: 12835170
    [No Abstract]   [Full Text] [Related]  

  • 6. Economics.
    Eisenberg JM
    JAMA; 1989 May; 261(19):2840-1. PubMed ID: 2709574
    [No Abstract]   [Full Text] [Related]  

  • 7. What a physician needs to know about cost-effectiveness: commentary.
    Cheitlin MD
    Cardiol Rev; 2000; 8(2):103. PubMed ID: 11174881
    [No Abstract]   [Full Text] [Related]  

  • 8. Eupompus gave splendour to art by numbers.
    Little JM
    Lancet; 1993 Apr; 341(8849):878-80. PubMed ID: 8096576
    [No Abstract]   [Full Text] [Related]  

  • 9. Perceived financial incentives, HMO market penetration, and physicians' practice styles and satisfaction.
    Hadley J; Mitchell JM; Sulmasy DP; Bloche MG
    Health Serv Res; 1999 Apr; 34(1 Pt 2):307-21. PubMed ID: 10199677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of a drug.
    Kaebnick GE
    Hastings Cent Rep; 2008; 38(5):2. PubMed ID: 18947124
    [No Abstract]   [Full Text] [Related]  

  • 11. The cost-effective medicine program.
    Egdahl RH; Bloem KD; Glass HS; Levin MA
    Ind Health Care (Cambridge Ma); 1985; 2():85-91. PubMed ID: 10287924
    [No Abstract]   [Full Text] [Related]  

  • 12. Interspeciality differences in medical resource utilization.
    Spann SJ
    J Fam Pract; 2000 Jan; 49(1):18-9. PubMed ID: 10678334
    [No Abstract]   [Full Text] [Related]  

  • 13. Medical professionalism in a commercialized health care market.
    Relman AS
    JAMA; 2007 Dec; 298(22):2668-70. PubMed ID: 18073363
    [No Abstract]   [Full Text] [Related]  

  • 14. The dangers of incorporating reimbursement data into clinical decision making.
    Teckie S; Potters L
    Pract Radiat Oncol; 2015; 5(4):274-6. PubMed ID: 25703531
    [No Abstract]   [Full Text] [Related]  

  • 15. How did we let this happen?
    Smith WB
    Foot Ankle Spec; 2020 Apr; 13(2):92. PubMed ID: 32285697
    [No Abstract]   [Full Text] [Related]  

  • 16. The patient-physician relationship: time to reimburse what we preach.
    Hensel WA
    JAMA; 1996 Jul; 276(1):27. PubMed ID: 8667528
    [No Abstract]   [Full Text] [Related]  

  • 17. Practice guidelines and professional autonomy in a universal health insurance system: the case of tissue plasminogen activator in Ontario.
    Naylor CD; Hollenberg AA
    Soc Sci Med; 1990; 31(12):1327-36. PubMed ID: 2126894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somnambulating into a paradigm shift--World Changes: Thomas Kuhn and the Nature of Science.
    Rashkis HA
    JAMA; 1994 Aug; 272(7):515-6. PubMed ID: 8046798
    [No Abstract]   [Full Text] [Related]  

  • 19. Understanding Financial Statements in Clinical Practice: A Primer.
    Makanji HS; Jenis LG
    Clin Spine Surg; 2017 May; 30(4):167-168. PubMed ID: 28394775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insurance coverage, physician recommendations, and access to emerging treatments: growth hormone therapy for childhood short stature.
    Finkelstein BS; Silvers JB; Marrero U; Neuhauser D; Cuttler L
    JAMA; 1998 Mar; 279(9):663-8. PubMed ID: 9496983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.